Construction Company Website Template Template Builderz. Should You Buy or Sell Co-Diagnostics Stock Get The Latest CODX Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. news website templates News & Magazine News Website Template HTML Codex.
#Codx news portable
The Company is also developing a portable polymerase chain reaction (PCR) device and test cups that are designed to bring PCR to patients in point-of-care and even at-home settings. It also sells diagnostic equipment from other manufacturers as self-contained lab systems. Newsroom Media Resources Advanced Search Co-Diagnostics, Inc. design specific tests for its Co-Dx PCR Home platform and to locate genetic markers for use in applications other than infectious disease. Share your opinion and gain insight from other stock traders and investors. (Nasdaq-CM: CODX) (the 'Company' or 'Co-Dx'), a molecular diagnostics company with a. (CODX) stock discussion in Yahoo Finances forum. The Company is engaged in developing, manufacturing and selling reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, including molecular tools for the detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. 16, 2023 /PRNewswire/ - Co-Diagnostics, Inc.
0 kommentar(er)
